These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29315140)

  • 1. High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes.
    Rayar M; Tron C; Jézéquel C; Beaurepaire JM; Petitcollin A; Houssel-Debry P; Camus C; Verdier MC; Dehlawi A; Lakéhal M; Desfourneaux V; Meunier B; Sulpice L; Bellissant E; Boudjema K; Lemaitre F
    Transplantation; 2018 Mar; 102(3):e108-e114. PubMed ID: 29315140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipients.
    Chen F; Yong JK; Shen C; Zhou T; Feng M; Wan P; Luo Y; Lin H; Qian Y; Xia Q
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1017-1027. PubMed ID: 38502358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation.
    Dopazo C; Bilbao I; García S; Gómez-Gavara C; Caralt M; Campos-Varela I; Castells L; Hidalgo E; Moreso F; Montoro B; Charco R
    Clin Transl Sci; 2022 Jun; 15(6):1544-1555. PubMed ID: 35373449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: Evolution, risk factors, and impact on patient outcomes.
    Defrancq C; De Wilde N; Raes A; Van Biervliet S; Vande Velde S; Van Winckel M; De Bruyne R; Prytuła A
    Pediatr Transplant; 2019 May; 23(3):e13388. PubMed ID: 30916883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation.
    Yin S; Wang X; Huang Z; Fan Y; Song T; Lin T
    Br J Clin Pharmacol; 2022 Jan; 88(1):75-83. PubMed ID: 33899267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies.
    Davis S; Gralla J; Klem P; Stites E; Wiseman A; Cooper JE
    Transplantation; 2020 Apr; 104(4):881-887. PubMed ID: 32224815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation.
    van der Veer MAA; Nangrahary N; Hesselink DA; Erler NS; Metselaar HJ; van Gelder T; Darwish Murad S
    Transplantation; 2019 Nov; 103(11):2329-2337. PubMed ID: 30801539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation.
    Xie W; Fan S; Liu R; Yan W; Su C; Zheng K; Wang X; Wang Z
    Transplant Rev (Orlando); 2024 Jul; 38(3):100842. PubMed ID: 38537484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Tacrolimus Intrapatient Variability on Allograft Rejection Frequency and Survival Following Liver Transplantation.
    Soares ME; Costa G; Guerra L; Morais MC; Vaz N; Codes L; Bittencourt PL
    Ther Drug Monit; 2024 Aug; 46(4):456-459. PubMed ID: 38648652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
    Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
    Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation.
    Park Y; Lee H; Eum SH; Kim HD; Ko EJ; Yang CW; Chung BH
    Front Immunol; 2021; 12():746013. PubMed ID: 34659243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
    Sablik KA; Clahsen-van Groningen MC; Hesselink DA; van Gelder T; Betjes MGH
    PLoS One; 2018; 13(5):e0196552. PubMed ID: 29746495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant Calcineurin Inhibitors Levels and Intrapatient Variability Are Not Associated With Long-term Outcomes Following Liver Transplantation.
    Di Maira T; Sapisochin G; Lilly L; Fonés V; Berenguer M
    Transplantation; 2020 Jun; 104(6):1201-1209. PubMed ID: 31609904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation.
    Gonzales HM; McGillicuddy JW; Rohan V; Chandler JL; Nadig SN; Dubay DA; Taber DJ
    Am J Transplant; 2020 Aug; 20(8):1969-1983. PubMed ID: 32406604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation.
    Shuker N; Shuker L; van Rosmalen J; Roodnat JI; Borra LC; Weimar W; Hesselink DA; van Gelder T
    Transpl Int; 2016 Nov; 29(11):1158-1167. PubMed ID: 27188932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications.
    Bardou FN; Guillaud O; Erard-Poinsot D; Chambon-Augoyard C; Thimonier E; Vallin M; Boillot O; Dumortier J
    Transpl Immunol; 2019 Oct; 56():101227. PubMed ID: 31351125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.
    Taber DJ; Su Z; Fleming JN; McGillicuddy JW; Posadas-Salas MA; Treiber FA; Dubay D; Srinivas TR; Mauldin PD; Moran WP; Baliga PK
    Transplantation; 2017 Dec; 101(12):2931-2938. PubMed ID: 28658199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.